Nuwellis, Inc. NUWE

Company Overview

Nuwellis, Inc. is a U.S.-based medical technology company focused on fluid management solutions for patients with fluid overload conditions, particularly in heart failure and critical care settings. The company operates within the cardiovascular and renal care medical device industries and develops ultrafiltration technologies designed to remove excess fluid from patients whose conditions may not respond adequately to diuretic therapy. Its primary commercial product platform is the Aquadex system, which is used in hospitals for controlled fluid removal in adult and pediatric patients. Revenue is primarily generated through the sale of capital equipment, disposable consumables, and related hospital-based services.

The company traces its origins to CHF Solutions, Inc., which was founded to commercialize ultrafiltration technologies targeting congestive heart failure treatment. It later rebranded as Nuwellis, Inc. to reflect a broader strategic focus on fluid management therapies. Nuwellis has positioned itself as a specialized player in extracorporeal fluid management with emphasis on precision fluid removal, particularly for patients suffering from acute decompensated heart failure, cardiorenal syndrome, and fluid overload associated with critical illness. Its differentiation is tied to the clinical specificity of the Aquadex platform and its focus on a niche but clinically significant patient population.